Related Experiment Videos
[Coronary surgery from the aspect of ambulatory care follow-up]
Insights
This study tracked 453 ischemic heart disease patients after aorto-coronary shunting (ACS). Five years post-surgery, many experienced symptom recurrence due to shunt issues and atherosclerosis, with calcium antagonists showing optimal therapeutic effects.
Area of Science:
- Cardiology
- Vascular Surgery
Context:
- Observational study of 453 patients with ischemic heart disease (IHD) undergoing aorto-coronary shunting (ACS).
- Assessed clinical outcomes and symptom recurrence at hospital discharge and five years post-operation.
Purpose:
- To evaluate the long-term efficacy of ACS in IHD patients.
- To identify causes of symptom recurrence and determine optimal pharmacotherapy.
Summary:
- Initial clinical improvement and angina relief were observed in 96.9% and 78.4% of patients, respectively, at discharge.
- Five years later, 46.1% remained free of stenocardia, while 53.9% reported retrosternal pain.
- Repeated coronarography revealed that insufficient venous shunt function and aggravated stenosing atherosclerosis contributed to recurrent stenocardiac syndrome.
- Pharmacodynamic testing indicated that monotherapy and combined therapy with calcium antagonists were optimal treatment strategies.
Impact:
- Provides long-term follow-up data on ACS outcomes in IHD patients.
- Highlights the importance of monitoring shunt function and atherosclerotic progression post-ACS.
- Establishes calcium antagonists as a key therapeutic option for managing recurrent symptoms.
Abstract:
The authors observed for a long-period 453 patients with the ischemic heart disease after the operation of aorto-coronary shunting (ACS). At discharge from the hospital, in 96.9% of the patients operated on, the clinical improvement of the state was noted, in 78.4% of them, the attacks of angina disappeared. Five years later, in 46.1% of the patients examined, there were no stenocardia, in 53.9%, retrosternal pain was noted. According to the findings of repeated coronarography, development of the stenocardiac syndrome is caused by insufficient function of the venous shunts and aggravation of stenosing atherosclerosis. By means of twin pharmacodynamic tests, it was established that monotherapy and combined therapy with calcium antagonists were the optimal ones.